370
Views
2
CrossRef citations to date
0
Altmetric
Cornea

Ocular Phenotype of Relaxin Gene Knockout (Rln-/-) Mice

, , , , , , , & show all
Pages 1211-1221 | Received 30 Sep 2019, Accepted 20 Feb 2020, Published online: 16 Mar 2020

References

  • Halls ML, Bathgate RA, Sutton SW, Dschietzig TB, Summers RJ; International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides. Pharmacol Rev. 2015;67(2):389–440. doi:10.1124/pr.114.009472.
  • Bathgate RA, Halls ML, van der Westhuizen ET, Callander GE, Kocan M, Summers RJ. Relaxin family peptides and their receptors. Physiol Rev. 2013;93(1):405–80. doi:10.1152/physrev.00001.2012.
  • Conrad KP. Emerging role of relaxin in the maternal adaptations to normal pregnancy: implications for preeclampsia. Semin Nephrol. 2011;31:15–32. doi:10.1016/j.semnephrol.2010.10.003.
  • Marshall SA, Senadheera SN, Parry LJ, Girling JE. The role of relaxin in normal and abnormal uterine function during the menstrual cycle and early pregnancy. Reprod Sci. 2017;24:342–54. doi:10.1177/1933719116657189.
  • Verkman AS. Aquaporins. Curr Biol. 2013;23(2):R52–5. doi:10.1016/j.cub.2012.11.025.
  • Jelinic M, Leo CH, Post Uiterweer ED, Sandow SL, Gooi JH, Wlodek ME, Conrad KP, Parkington H, Tare M, Parry LJ. Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykinin-mediated relaxation after in vivo serelaxin treatment. Faseb J. 2014;28:275–87. doi:10.1096/fj.13-233429.
  • Leo CH, Jelinic M, Ng HH, Tare M, Parry LJ. Time-dependent activation of prostacyclin and nitric oxide pathways during continuous i.v. infusion of serelaxin (recombinant human H2 relaxin). Br J Pharmacol. 2016;173:1005–17. doi:10.1111/bph.v173.6.
  • Novak J, Parry LJ, Matthews JE, Kerchner LJ, Indovina K, Hanley-Yanez K, Doty KD, Debrah DO, Shroff SG, Conrad KP. Evidence for local relaxin ligand-receptor expression and function in arteries. Faseb J. 2006;20:2352–62. doi:10.1096/fj.06-6263com.
  • Ng HH, Leo CH, Prakoso D, Qin C, Ritchie RH, Parry LJ. Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes. Sci Rep. 2017;7:39604. doi:10.1038/srep39604.
  • Jelinic M, Leo CH, Marshall SA, Senadheera SN, Parry LJ, Tare M. Short-term (48 hours) intravenous serelaxin infusion has no effect on myogenic tone or vascular remodeling in rat mesenteric arteries. Microcirculation. 2017;24:e12371. doi:10.1111/micc.12371.
  • Leo CH, Jelinic M, Parkington HC, Tare M, Parry LJ. Acute intravenous injection of serelaxin (recombinant human relaxin-2) causes rapid and sustained bradykinin-mediated vasorelaxation. J Am Heart Assoc. 2014;3:e000493. doi:10.1161/JAHA.113.000493.
  • Ng HH, Leo CH, Parry LJ. Serelaxin (recombinant human relaxin-2) prevents high glucose-induced endothelial dysfunction by ameliorating prostacyclin production in the mouse aorta. Pharmacol Res. 2016;107:220–28. doi:10.1016/j.phrs.2016.03.011.
  • Leo CH, Jelinic M, Gooi JH, Tare M, Parry LJ. A vasoactive role for endogenous relaxin in mesenteric arteries of male mice. PLoS One. 2014;9:e107382. doi:10.1371/journal.pone.0107382.
  • Samuel CS, Royce SG, Hewitson TD, Denton KM, Cooney TE, Bennett RG. Anti-fibrotic actions of relaxin. Br J Pharmacol. 2017;174:962–76. doi:10.1111/bph.13529.
  • Lam M, Royce SG, Samuel CS, Bourke JE. Serelaxin as a novel therapeutic opposing fibrosis and contraction in lung diseases. Pharmacol Ther. 2018;187:61–70. doi:10.1016/j.pharmthera.2018.02.004.
  • Jelinic M, Marshall SA, Stewart D, Unemori E, Parry LJ, Leo CH. The peptide hormone relaxin: from bench to bedside. Am J Physiol Regul Integr Comp Physiol. 2018;314:R753–R760. doi:10.1152/ajpregu.00276.2017.
  • Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Sherwood OD, Hsueh AJ. Activation of orphan receptors by the hormone relaxin. Science. 2002;295(5555):671–74. doi:10.1126/science.1065654.
  • Hampel U, Klonisch T, Sel S, Schulze U, Garreis F, Paulsen FP. Relaxin 2 is functional at the ocular surface and promotes corneal wound healing. Invest Ophthalmol Vis Sci. 2012;53(12):7780–90. doi:10.1167/iovs.12-10714.
  • Paterson GD, Miller SJ. Hormonal influence in simple glaucoma. A preliminary report. Br J Ophthalmol. 1963;47:129–37. doi:10.1136/bjo.47.3.129.
  • Hampel U, Träger K, Liu H, Teister J, Grus F, Prokosch-Willing V. Relaxin 2 fails to lower intraocular pressure and to dilate retinal vessels in rats. Int Ophthalmol. 2018. doi:10.1007/s10792-018-0884-4.
  • Zhao L, Roche PJ, Gunnersen JM, Hammond VE, Tregear GW, Wintour EM, Beck F. Mice without a functional relaxin gene are unable to deliver milk to their pups. Endocrinology. 1999;140(1):445–53. doi:10.1210/endo.140.1.6404.
  • Gooi JH, Richardson ML, Jelinic M, Girling JE, Wlodek ME, Tare M, Parry LJ. Enhanced uterine artery stiffness in aged pregnant relaxin mutant mice is reversed with exogenous relaxin treatment. Biol Reprod. 2013;89(1):18. doi:10.1095/biolreprod.113.108118.
  • Downie LE, Stainer MJ, Chinnery HR. Monitoring of strain-dependent responsiveness to TLR activation in the mouse anterior segment using SD-OCT. Invest Ophthalmol Vis Sci. 2014;55(12):8189–99. doi:10.1167/iovs.14-15595.
  • Marshall SA, Ng L, Unemori EN, Girling JE, Parry LJ. Relaxin deficiency results in increased expression of angiogenesis- and remodelling-related genes in the uterus of early pregnant mice but does not affect endometrial angiogenesis prior to implantation. Reprod Biol Endocrinol. 2016;14:11. doi:10.1186/s12958-016-0148-y.
  • Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):e45. doi:10.1093/nar/29.9.e45.
  • Bathgate RA, Ivell R, Sanborn BM, Sherwood OD, Summers RJ. International union of pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol Rev. 2006;58(1):7–31. doi:10.1124/pr.58.1.9.
  • Kuchel PW. The story of the discovery of aquaporins: convergent evolution of ideas–but who got there first? Cell Mol Biol (Noisy-le-grand). 2006;52:2–5.
  • Verkman AS, Ruiz-Ederra J, Levin MH. Functions of aquaporins in the eye. Prog Retin Eye Res. 2008;27(4):420–33. doi:10.1016/j.preteyeres.2008.04.001.
  • Hamann S, Zeuthen T, La Cour M, Nagelhus EA, Ottersen OP, Agre P, Nielsen S. Aquaporins in complex tissues: distribution of aquaporins 1-5 in human and rat eye. Am J Physiol. 1998;274(5 Pt 1):C1332–45. doi:10.1152/ajpcell.1998.274.5.C1332.
  • Soh YM, Tiwari A, Mahendroo M, Conrad KP, Parry LJ. Relaxin regulates hyaluronan synthesis and aquaporins in the cervix of late pregnant mice. Endocrinology. 2012;153(12):6054–64. doi:10.1210/en.2012-1577.
  • Patel SP, Hoek ANV, Joyce NC, Colby K. Expression of aquaporin 4 in corneal endothelial cells. Invest Ophthalmol Vis Sci. 2010;51:693–693.
  • Levin MH, Verkman AS. Aquaporin-dependent water permeation at the mouse ocular surface: in vivo microfluorimetric measurements in cornea and conjunctiva. Invest Ophthalmol Vis Sci. 2004;45(12):4423–32. doi:10.1167/iovs.04-0816.
  • Zhang D, Vetrivel L, Verkman AS. Aquaporin deletion in mice reduces intraocular pressure and aqueous fluid production. J Gen Physiol. 2002;119(6):561–69. doi:10.1085/jgp.20028597.
  • Goldich Y, Cooper M, Barkana Y, Tovbin J, Lee Ovadia K, Avni I, Zadok D. Ocular anterior segment changes in pregnancy. J Cataract Refract Surg. 2014;40(11):1868–71. doi:10.1016/j.jcrs.2014.02.042.
  • Green K, Phillips CI, Cheeks L, Slagle T. Aqueous humor flow rate and intraocular pressure during and after pregnancy. Ophthalmic Res. 1988;20(6):353–57. doi:10.1159/000266751.
  • Weinreb RN, Lu A, Beeson C. Maternal corneal thickness during pregnancy. Am J Ophthalmol. 1988;105(3):258–60. doi:10.1016/0002-9394(88)90006-2.
  • Efe YK, Ugurbas SC, Alpay A, Ugurbas SH. The course of corneal and intraocular pressure changes during pregnancy. Can J Ophthalmol. 2012;47(2):150–54. doi:10.1016/j.jcjo.2012.01.004.
  • Atas M, Duru N, Ulusoy DM, Altinkaynak H, Duru Z, Acmaz G, Atas FK, Zararsiz G. Evaluation of anterior segment parameters during and after pregnancy. Cont Lens Anterior Eye. 2014;37(6):447–50. doi:10.1016/j.clae.2014.07.013.
  • Horven I, Gjonnaess H. Corneal indentation pulse and intraocular pressure in pregnancy. Arch Ophthalmol. 1974;91(2):92–98. doi:10.1001/archopht.1974.03900060098002.
  • Naderan M, Jahanrad A. Anterior, posterior and biomechanical parameters of cornea during pregnancy in healthy eyes: a cohort study. Br J Ophthalmol. 2018 Mar;102(3):309–312.
  • Khan-Dawood FS, Goldsmith LT, Weiss G, Dawood MY. Human corpus luteum secretion of relaxin, oxytocin, and progesterone. J Clin Endocrinol Metab. 1989;68(3):627–31. doi:10.1210/jcem-68-3-627.
  • Petersen LK, Vogel I, Agger AO, Westergard J, Nils M, Uldbjerg N. Variations in serum relaxin (hRLX-2) concentrations during human pregnancy. Acta Obstet Gynecol Scand. 1995;74(4):251–56. doi:10.3109/00016349509024444.
  • Kim HS, Shang T, Chen Z, Pflugfelder SC, Li DQ. TGF-beta1 stimulates production of gelatinase (MMP-9), collagenases (MMP-1, −13) and stromelysins (MMP-3, −10, −11) by human corneal epithelial cells. Exp Eye Res. 2004;79(2):263–74. doi:10.1016/j.exer.2004.05.003.
  • Ye HQ, Maeda M, Yu FS, Azar DT. Differential expression of MT1-MMP (MMP-14) and collagenase III (MMP-13) genes in normal and wounded rat corneas. Invest Ophthalmol Vis Sci. 2000;41:2894–99.
  • Azar DT, Hahn TW, Jain S, Yeh YC, Stetler-Stevensen WG. Matrix metalloproteinases are expressed during wound healing after excimer laser keratectomy. Cornea. 1996;15:18–24.
  • Jelinic M, Tare M, Conrad KP, Parry LJ. Differential effects of relaxin deficiency on vascular aging in arteries of male mice. Age (Dordr). 2015;37(4):9803. doi:10.1007/s11357-015-9803-z.
  • Samuel CS, Zhao C, Bond CP, Hewitson TD, Amento EP, Summers RJ. Relaxin-1-deficient mice develop an age-related progression of renal fibrosis. Kidney Int. 2004;65(6):2054–64. doi:10.1111/j.1523-1755.2004.00628.x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.